Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
MuSK CAART in Myasthenia Gravis: NCT05451212 Clinical Landscape Report 2026
15 October 2026
NCT05451212 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBM-H803 in Hemophilia A: NCT05454774 Clinical Landscape Report 2026
15 October 2026
NCT05454774 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ristoglogene Autogetemcel in Vaso-occlusive crisis: NCT05456880 Clinical Landscape Report 2026
15 October 2026
NCT05456880 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Diabetes Mellitus, Type 2: NCT05459701 Clinical Landscape Report 2026
15 October 2026
NCT05459701 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rencofilstat in Fibrosis, Liver: NCT05461105 Clinical Landscape Report 2026
15 October 2026
NCT05461105 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Arginine in Anemia, Sickle Cell: NCT05470998 Clinical Landscape Report 2026
15 October 2026
NCT05470998 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ASC-41 in Metabolic Dysfunction Associated Steatohepatitis: NCT05462353 Clinical Landscape Report 2026
15 October 2026
NCT05462353 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Human Cord Derived MSC (Life science) in Idiopathic Pulmonary Fibrosis: NCT05468502 Clinical Landscape Report 2026
15 October 2026
NCT05468502 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Anemia, Sickle Cell: NCT05470270 Clinical Landscape Report 2026
15 October 2026
NCT05470270 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Crizanlizumab-TMCA in Anemia, Sickle Cell: NCT05469828 Clinical Landscape Report 2026
15 October 2026
NCT05469828 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBT-877 in Idiopathic Pulmonary Fibrosis: NCT05483907 Clinical Landscape Report 2026
15 October 2026
NCT05483907 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PRS-220 in Idiopathic Pulmonary Fibrosis: NCT05473533 Clinical Landscape Report 2026
15 October 2026
NCT05473533 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.